Education

Fellowship Programme DURATION: Two (2) months CANDIDATES: This fellowship is offered to 2-4 physicians per year. VENUE: Currently through the Joint Red Cell Unit, Haematology Department of the University College London NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, UK. DEADLINE FOR APPLICATION: 31st March 2019 OUR SPECIALIST TEAM: Prof John Porter, Supervisor ...

This section is dedicated to alpha (α-) thalassaemia. THE MAJOR ALPHA (α-) THALASSAEMIAS ARE: HbH disease α-thalassaemia Hydrops Foetalis (=Hb Bart’s Hydrops Foetalis) Many diseases in humans are caused by abnormalities in the blood and these are categorized according to the component of the blood which is affected: white cell ...

OUR SPECIALIST TEAM: Prof John Porter, Supervisor Dr Perla Eleftheriou, Coordinator and many other valuable colleagues. FUNDING: A stipend of $2000 USD/month for each successful candidate, which intends to cover the successful candidate’s accommodation, daily transportation and basic living expenses. Any expenses above this amount will be the responsibility of the ...

We feel extremely privileged and delighted to provide the official completion report of the last TIF – Renzo Galanello Fellowship which took place between 3rd of October – 30th of November 2016 through the Joint Red Cell Unit of the Haematology Department of the University College London Hospital (UCLH) in ...

Non-Transfusion Dependent Thalassaemias (NTDTs) is a term used to label patients who do not need regular blood transfusions for survival but may need occasional or even frequent transfusions for defined periods of time.

At present, the only available approach to curing thalassaemia is bone marrow transplantation, following specific requirements that both the donor and patient must fulfil. Gene therapy is being studied as a potential cure for some patients. Bone Marrow Transplantation Bone Marrow Transplantation (BMT) or Haematopoietic Stem Cell Transplantation (HSCT) is a ...

Clinical trials are experiments or observations carried out in clinical research, designed to answer specific questions about new treatments such as novel vaccines, drugs etc. for further study and comparison.

What is beta thalassaemia This section is dedicated to beta (β-) thalassaemia syndromes of which β-thalassaemia major, also known as Mediterranean anaemia or Cooley’s Anaemia, is the clinically most severe one. THE MAJOR BETA (β-) THALASSAEMIA SYNDROMES ARE: β-thalassaemia major β-thalassaemia intermedia HbE/β-thalassaemia Other rare thalassaemias Many diseases in humans ...